Literature DB >> 23070472

Alteration in glutathione content and associated enzyme activities in the synaptic terminals but not in the non-synaptic mitochondria from the frontal cortex of Parkinson's disease brains.

G Harish1, Anita Mahadevan, M M Srinivas Bharath, S K Shankar.   

Abstract

Altered redox dynamics contribute to physiological aging and Parkinson's disease (PD). This is reflected in the substantia nigra (SN) of PD patients as lowered antioxidant levels and elevated oxidative damage. Contrary to this observation, we previously reported that non-SN regions such as caudate nucleus and frontal cortex (FC) exhibited elevated antioxidants and lowered mitochondrial and oxidative damage indicating constitutive protective mechanisms in PD brains. To investigate whether the sub-cellular distribution of antioxidants could contribute to these protective effects, we examined the distribution of antioxidant/oxidant markers in the neuropil fractions [synaptosomes, non-synaptic mitochondria and cytosol] of FC from PD (n = 9) and controls (n = 8). In the control FC, all the antioxidant activities [Superoxide dismutase (SOD), glutathione (GSH), GSH peroxidase (GPx), GSH-S-transferase (GST)] except glutathione reductase (GR) were the highest in cytosol, but several fold lower in mitochondria and much lower in synaptosomes. However, FC synaptosomes from PD brains had significantly higher levels of GSH (p = 0.01) and related enzymes [GPx (p = 0.02), GR (p = 0.06), GST (p = 0.0001)] compared to controls. Conversely, mitochondria from the FC of PD cases displayed elevated SOD activity (p = 0.02) while the GSH and related enzymes were relatively unaltered. These changes in the neuropil fractions were associated with unchanged or lowered oxidative damage. Further, the mitochondrial content in the synaptosomes of both PD and control brains was ≥five-fold lower compared to the non-synaptic mitochondrial fraction. Altered distribution of oxidant/antioxidant markers in the neuropil fractions of the human brain during aging and PD has implications for (1) degenerative and protective mechanisms (2) distinct antioxidant mechanisms in synaptic terminals compared to other compartments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070472     DOI: 10.1007/s11064-012-0907-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  59 in total

1.  Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex.

Authors:  A Radunović; W G Porto; S Zeman; P N Leigh
Journal:  Neurosci Lett       Date:  1997-12-19       Impact factor: 3.046

2.  Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.

Authors:  Rajeswara Babu Mythri; C Venkateshappa; G Harish; Anita Mahadevan; Uday B Muthane; T C Yasha; M M Srinivas Bharath; S K Shankar
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

3.  Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease.

Authors:  C B Pocernich; A L Cardin; C L Racine; C M Lauderback; D A Butterfield
Journal:  Neurochem Int       Date:  2001-08       Impact factor: 3.921

4.  Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Authors:  D T Dexter; C J Carter; F R Wells; F Javoy-Agid; Y Agid; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

Review 5.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

6.  Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice.

Authors:  M Martínez; M L Ferrándiz; A Díez; J Miquel
Journal:  Mech Ageing Dev       Date:  1995-09-29       Impact factor: 5.432

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Biochemical analysis of protein stability in human brain collected at different post-mortem intervals.

Authors:  Ramesh Chandana; R B Mythri; Anita Mahadevan; S K Shankar; M M Srinivas Bharath
Journal:  Indian J Med Res       Date:  2009-02       Impact factor: 2.375

9.  Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

Authors:  D T Dexter; F R Wells; A J Lees; F Agid; Y Agid; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

10.  Effect of premortem and postmortem factors on the distribution and preservation of antioxidant activities in the cytosol and synaptosomes of human brains.

Authors:  G Harish; C Venkateshappa; Anita Mahadevan; Nupur Pruthi; M M Srinivas Bharath; S K Shankar
Journal:  Biopreserv Biobank       Date:  2012-06       Impact factor: 2.300

View more
  7 in total

1.  Mitochondrial Dysfunction in Rabies Virus-Infected Human and Canine Brains.

Authors:  Pulleri Kandi Harsha; Sathyanarayanan Ranganayaki; Gowri Yale; Gourav Dey; Kiran K Mangalaparthi; Anusha Yarlagadda; B K Chandrasekhar Sagar; Anita Mahadevan; M M Srinivas Bharath; Reeta S Mani
Journal:  Neurochem Res       Date:  2022-02-28       Impact factor: 3.996

2.  Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.

Authors:  Elena A Ostrakhovitch; Eun-Suk Song; Jessica K A Macedo; Matthew S Gentry; Jorge E Quintero; Craig van Horne; Tritia R Yamasaki
Journal:  Neurosci Lett       Date:  2021-12-28       Impact factor: 3.046

3.  Altered prefrontal neurochemistry in the DJ-1 knockout mouse model of Parkinson's disease: complementary semi-quantitative analyses with in vivo magnetic resonance spectroscopy and MALDI-MSI.

Authors:  Wei Chen; Huihui Liu; Sijie Liu; Yan Kang; Zongxiu Nie; Hao Lei
Journal:  Anal Bioanal Chem       Date:  2022-10-08       Impact factor: 4.478

Review 4.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

Review 5.  Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yeonggwang Hwang; Naveen Sharma; Duy-Khanh Dang; Bao-Trong Nguyen; Seung-Yeol Nah; Choon-Gon Jang; Guoying Bing; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2021-07-20       Impact factor: 4.946

Review 6.  Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.

Authors:  Hyungsun Park; Jongyoon Kim; Chihoon Shin; Seongju Lee
Journal:  Antioxidants (Basel)       Date:  2021-04-28

Review 7.  Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.

Authors:  Samantha Giordano; Victor Darley-Usmar; Jianhua Zhang
Journal:  Redox Biol       Date:  2013-12-25       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.